White House says US can roll out COVID boosters next week

The Biden administration’s embattled plan to dispense COVID-19 booster shots to most Americans faced its first key hurdle on Friday as a government advisory panel met to decide whether to recommend extra doses of Pfizer vaccine. (AP)

• In August, President Joe Biden said the government would provide boosters in the week of Sept. 20
• Critics have said the Biden administration's booster plan is putting pressure on scientists

WASHINGTON: The United States is ready to roll out COVID-19 vaccine booster shots next week but will do so only if health regulators approve the plan, White House officials said on Friday.
In August, President Joe Biden said the government would provide boosters in the week of Sept. 20 to address waning vaccine immunity and the highly transmissible Delta variant.
“We’ve been working through the last few weeks, intensely with our partners, our governors, state, and local health officials, federal pharmacy programs, the community health centers to ensure that we are ready for next week,” White House coronavirus response coordinator Jeff Zientz said at a briefing.
While some health officials, other countries and vaccine makers say boosters are needed, many experts disagree, including two top scientists at the Food and Drug Administration who are leaving the agency later this year.
Surgeon General Vivek Murthy told reporters boosters will be available once the FDA and the Centers for Disease Control and Prevention approve the plan. Critics have said the Biden administration’s booster plan is putting pressure on scientists or getting ahead of their evaluations.
“We have always said that this initial plan would be contingent on the FDA and the CDC’s independent evaluation. We will follow that evaluation and their recommendations. We will make sure our final plan reflects it,” he said.
Murthy was among eight top US health officials including the FDA and CDC chiefs who have said boosters are necessary.
A panel of independent expert advisers to the FDA is debating whether Americans should receive a booster dose of the Pfizer/BioNTech vaccine and was set to vote later on Friday.
The CDC’s Advisory Committee on Immunization Practices will meet next week to discuss boosters.